Neuropathic pain associated with Nav1.7 mutations. Clinical picture and treatment

被引:3
|
作者
Doppler, K. [1 ]
Sommer, C. [1 ]
机构
[1] Univ Klinikum Wurzburg, Neurol Klin & Poliklin, D-97080 Wurzburg, Germany
来源
NERVENARZT | 2013年 / 84卷 / 12期
关键词
Nav1.7; SCN9A mutation; Small fiber neuropathy; Erythromelalgia; polymorphism; SMALL-FIBER NEUROPATHY; CHANNEL ALPHA-SUBUNIT; FAMILIAL ERYTHROMELALGIA; SODIUM-CHANNELS; NA(V)1.7; SCN9A; DISORDER; POLYMORPHISM; ERYTHERMALGIA; SYMPTOMS;
D O I
10.1007/s00115-012-3621-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Voltage-gated sodium channels are essential for electrogenesis in excitable cells. The isoform Nav1.7 is primarily expressed in nociceptors. Mutations of the SCN9A gene, which codes for the alpha-subunit of Nav1.7, are the cause of primary erythromelalgia and paroxysmal extreme pain disorder, two rare neuropathic pain conditions. Recent studies have shown that mutations in the SCN9A gene are the cause of a subgroup of idiopathic small fiber neuropathies and that polymorphisms of SCN9A are associated with an increase in susceptibility to pain. These findings not only contribute to the understanding of the pathophysiology of neuropathic pain but also offer targets for a more specific pain therapy.
引用
收藏
页码:1428 / +
页数:6
相关论文
共 50 条
  • [1] Neuropathische Schmerzen durch Nav1.7-MutationenKlinik und TherapieNeuropathic pain associated with Nav1.7 mutationsClinical picture and treatment
    K. Doppler
    C. Sommer
    Der Nervenarzt, 2013, 84 : 1428 - 1435
  • [2] UnCRMPing Nav1.7 to treat trigeminal neuropathic pain
    Antunes, Flavia T. T.
    Zamponi, Gerald W.
    PAIN, 2024, 165 (03) : 493 - 495
  • [3] Benzazepinone Nav1.7 blockers:: Potential treatments for neuropathic pain
    Hoyt, Scott B.
    London, Clare
    Ok, Hyun
    Gonzalez, Edward
    Duffy, Joseph L.
    Abbadie, Catherine
    Dean, Brian
    Felix, John P.
    Garcia, Maria L.
    Jochnowitz, Nina
    Karanam, Bindhu V.
    Li, Xiaohua
    Lyons, Kathryn A.
    McGowan, Erin
    MacIntyre, D. Euan
    Martin, William J.
    Priest, Birgit T.
    Smith, McHardy M.
    Tschirret-Guth, Richard
    Warren, Vivien A.
    Williams, Brande S.
    Kaczorowski, Gregory J.
    Parsons, William H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (22) : 6172 - 6177
  • [4] Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7
    Sangsu Bang
    Jiho Yoo
    Xingrui Gong
    Di Liu
    Qingjian Han
    Xin Luo
    Wonseok Chang
    Gang Chen
    Sang-Taek Im
    Yong Ho Kim
    Judith A.Strong
    Ma-Zhong Zhang
    Jun-Ming Zhang
    Seok-Yong Lee
    Ru-Rong Ji
    NeuroscienceBulletin, 2018, 34 (01) : 22 - 41
  • [5] Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7
    Bang, Sangsu
    Yoo, Jiho
    Gong, Xingrui
    Liu, Di
    Han, Qingjian
    Luo, Xin
    Chang, Wonseok
    Chen, Gang
    Im, Sang-Taek
    Kim, Yong Ho
    Strong, Judith A.
    Zhang, Ma-Zhong
    Zhang, Jun-Ming
    Lee, Seok-Yong
    Ji, Ru-Rong
    NEUROSCIENCE BULLETIN, 2018, 34 (01) : 22 - 41
  • [6] Nav1.7 inhibitors for the treatment of chronic pain
    McKerrall, Steven J.
    Sutherlin, Daniel P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (19) : 3141 - 3149
  • [7] Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain
    Frost, Jennifer M.
    DeGoey, David A.
    Shi, Lei
    Gum, Rebecca J.
    Fricano, Meagan M.
    Lundgaard, Greta L.
    El-Kouhen, Odile F.
    Hsieh, Gin C.
    Neelands, Torben
    Matulenko, Mark A.
    Daanen, Jerome F.
    Pai, Madhavi
    Ghoreishi-Haack, Nayereh
    Zhan, Cenchen
    Zhang, Xu-Feng
    Kort, Michael E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (07) : 3373 - 3391
  • [8] Discovery of a Novel Class of State-Dependent NaV1.7 Inhibitors for the Treatment of Neuropathic Pain
    Tanaka, Kyosuke
    Kobayashi, Hiroyuki
    Suzuki, Sayaka
    Shibuya, Satoshi
    Kimoto, Hiroko
    Domon, Yuki
    Kubota, Kazufumi
    Kitano, Yutaka
    Yokoyama, Tomihisa
    Shimizugawa, Akiko
    Koishi, Ryuta
    Fujiwara, Chie
    Asano, Daigo
    Shinozuka, Tsuyoshi
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (07) : 653 - 663
  • [9] Interplay of Nav1.8 and Nav1.7 channels drives neuronal hyperexcitability in neuropathic pain
    Vasylyev, Dmytro V.
    Zhao, Peng
    Schulman, Betsy R.
    Waxman, Stephen G.
    JOURNAL OF GENERAL PHYSIOLOGY, 2024, 156 (11):
  • [10] Targeting Nav1.7 and Nav1.8 with a PIKfyve inhibitor to reverse inflammatory and neuropathic pain
    Rodriguez-Palma, Erick J.
    Loya-Lopez, Santiago
    Min, Sophia M.
    Calderon-Rivera, Aida
    Gomez, Kimberly
    Khanna, Rajesh
    Axtman, Alison D.
    NEUROBIOLOGY OF PAIN, 2025, 17